Prof. Dr. Med. Michael Untch

Prof. Dr. Med. Michael Untch

Gynaecologist and Obstetrician, Medical Oncologist

Fellowship, Graduation

ChatYou are Viewing our Top Doctor

ChatChat on WhatsApp

About Prof. Dr. Med. Michael Untch

Prof. Dr. Med. Michael Untch is a world-renowned Gynaecologist and Obstetrician, Medical Oncologist based in Berlin, Germany, with over 38 years of experience in breast cancer research and treatment. He is internationally recognised for pioneering work in HER2-positive breast cancer therapy, neoadjuvant chemotherapy, and sentinel lymph node surgery.

  • 38+ years of clinical and research experience in gynaecologic oncology
  • Chief Physician, Department of Gynaecology, Obstetrics & Interdisciplinary Breast Cancer Centre since 2006
  • Over 800 scientific publications in leading international journals
  • Principal investigator of landmark KATHERINE breast cancer trial (NEJM publication)
  • Consults in German, English and regularly treats international patients

Qualifications & Credentials

Medical Degrees

  • Medical Degree (M.D.) — Ludwig-Maximilians University, Munich, 1984
  • Doctoral Dissertation (M.D. Thesis), Magna Cum Laude — University of Munich, 1987
  • Habilitation / Professorship — 2005

Fellowships & Special Training

  • Research Associate, Gynecologic Oncology Laboratory — University Hospital Munich-Grosshadern, 1984–1986
  • Postdoctoral Research Fellowship, Department of Gynecologic Oncology — University of Miami School of Medicine, USA, 1990–1991
  • Obstetrics & Gynaecology Residency — Ludwig-Maximilians University, Munich, 1990–1992

Certifications & Accreditations

  • German Medical Council Registration (Ärztekammer)
  • Board-Certified Specialist in Gynaecology & Obstetrics
  • Centre for Gynecologic Oncology certification — German Cancer Society

Areas of Expertise

Major Conditions Treated

  • Breast Cancer (early, locally advanced and metastatic)
  • HER2-positive Breast Cancer
  • Triple-Negative Breast Cancer
  • Ovarian Cancer
  • Cervical Cancer
  • Endometrial / Uterine Cancer
  • Uterine Sarcoma
  • Benign Gynaecological Conditions (Fibroids, Endometriosis, Polyps)
  • Urinary Incontinence
  • Precancerous Conditions of the Female Reproductive Organs

Sub-specialties

  • Breast Cancer Surgery & Oncology: One of Germany's leading experts in preoperative systemic therapy, oncoplastic surgery and sentinel lymph node surgery — a top choice among patients seeking best breast cancer doctor in Germany.
  • Gynaecologic Oncology: Advanced cancer surgery for ovarian, cervical and uterine malignancies at a Centre certified by the German Cancer Society.
  • Minimally Invasive Gynaecological Surgery: Laparoscopic uterus-conserving surgery for fibroids, ovarian disease and endometriosis.

Advanced Procedures & Treatments

  • Neoadjuvant / Preoperative Systemic Therapy for Breast Cancer
  • Sentinel Lymph Node Biopsy
  • Breast-Conserving Surgery & Oncoplastic Reconstruction
  • Mastectomy (Simple, Modified Radical, Skin-Sparing)
  • Antibody-Drug Conjugate Therapy (T-DM1 / Trastuzumab Emtansine)
  • Immunotherapy with Checkpoint Inhibitors (Pembrolizumab, Durvalumab)
  • CDK4/6 Inhibitor Therapy for ER+/HER2- Breast Cancer
  • Laparoscopic Hysterectomy & Myomectomy
  • Radical Hysterectomy for Cervical Cancer
  • Debulking Surgery for Ovarian Cancer

List of Disease and Treatment for which Prof. Dr. Med. Michael Untch can be consulted

Professional Experience

Current Affiliation

  • Helios Klinikum Berlin-Buch — Chief Physician, Department of Gynaecology, Obstetrics & Mammology, and Head of the Interdisciplinary Breast Cancer Centre, January 2006–Present

Past Affiliations

  • Ludwig-Maximilians University, Munich — Obstetrics & Gynaecology Fellow, 1990–1992
  • University of Miami School of Medicine, USA — Postdoctoral Research Associate, Gynecologic Oncology, 1990–1991
  • University Hospital Munich-Grosshadern — Research Associate, Gynecologic Oncology Laboratory, 1984–1986

Academic & Research Roles

  • Professor of Gynaecology, Ludwig-Maximilians University, Munich — since 2005
  • Principal Investigator — KATHERINE Trial (New England Journal of Medicine publication)
  • Invited Faculty — ASCO, ESMO, SABCS, ABC international breast cancer conferences

Key Achievements

  • 38+ years of clinical experience in gynaecologic oncology
  • Over 800 scientific publications in national and international journals
  • Named on the Good Advice Doctors List (Focus Ärzteliste), Germany
  • Centre certified by the German Cancer Society for Gynaecologic Oncology under his leadership
  • Regularly treats international patients from across Europe, the Gulf, Russia and the CIS

Awards & Recognitions

National & International Awards

  • Good Advice Doctors List (Focus Ärzteliste), Germany — Breast Cancer Specialist
  • Doctoral Dissertation Magna Cum Laude — University of Munich, 1987

Professional Memberships

  • German Society for Gynaecology and Obstetrics (DGGG)
  • German Cancer Society (Deutsche Krebsgesellschaft)
  • American Society of Clinical Oncology (ASCO)
  • European Society of Medical Oncology (ESMO)
  • AGO Breast Committee (Arbeitsgemeinschaft Gynäkologische Onkologie)

Research & Publications

Published Papers (Selected)

  • von Minckwitz G, Huang CS, Mano MS, Loibl S, Mamounas EP, Untch M, et al. "Trastuzumab Emtansine for Residual Invasive HER2-Positive Breast Cancer." New England Journal of Medicine. 2019;380(7):617-628. (KATHERINE trial)
  • Untch M et al. "Neoadjuvant pertuzumab and trastuzumab with or without an anthracycline-based chemotherapy in HER2-positive early breast cancer." Annals of Oncology.
  • Untch M et al. "Urokinase-type plasminogen activator and plasminogen activator inhibitor-1 predict survival in patients with early breast cancer." European Journal of Cancer.
  • Over 800 additional peer-reviewed articles in Lancet Oncology, JCO, NEJM, Breast Cancer Research & Treatment, and Cancer.

Ongoing Research & Clinical Interests

  • HER2-positive breast cancer — targeted therapy and antibody-drug conjugates
  • Triple-negative breast cancer — immune checkpoint inhibitors
  • CDK4/6 inhibitors in ER+/HER2- breast cancer (adjuvant and neoadjuvant settings)
  • Denosumab and bone-modifying agents in the prevention of metastases
  • Side-effect management in metastatic breast cancer

Estimated Treatment Costs

Procedure / ConsultationEstimated Cost (EUR)Estimated Cost (USD)
Specialist Consultation€250 – €500$270 – $540
Breast-Conserving Surgery with Sentinel Node Biopsy€8,000 – €15,000$8,600 – $16,200
Mastectomy with Reconstruction€15,000 – €30,000$16,200 – $32,400
Neoadjuvant Chemotherapy (full course)€20,000 – €50,000$21,600 – $54,000
Targeted Therapy (Trastuzumab / T-DM1 per cycle)€3,500 – €8,000$3,800 – $8,600
Radical Hysterectomy for Cervical Cancer€12,000 – €25,000$13,000 – $27,000

*Indicative estimates only. Actual costs subject to hospital pricing, case complexity, and insurance. Contact Cancer Rounds for a personalised quote.

Frequently Asked Questions

1. What advanced technologies does Prof. Dr. Med. Michael Untch use in Gynaecologist and Obstetrician, Medical Oncologist treatment?

Prof. Untch uses advanced neoadjuvant systemic therapy, sentinel lymph node biopsy with gamma probe, antibody-drug conjugates (T-DM1), immune checkpoint inhibitors (pembrolizumab, durvalumab), CDK4/6 inhibitors, laparoscopic gynaecological surgery, and oncoplastic breast reconstruction — among the most advanced breast cancer treatment options in Germany and globally. Virtual consultations are available for international patients.

2. What conditions does Prof. Dr. Med. Michael Untch specialize in treating?

Prof. Untch specialises in breast cancer (early, locally advanced and metastatic), HER2-positive and triple-negative breast cancer, ovarian cancer, cervical cancer, endometrial cancer, uterine sarcoma, fibroids, endometriosis and precancerous gynaecological conditions — making him a leading choice among international patients seeking the best breast cancer specialist in Berlin, Germany.

3. How do I book an appointment with Prof. Dr. Med. Michael Untch?

Appointments with Prof. Dr. Med. Michael Untch can be booked directly through the Cancer Rounds website or by contacting their international patient department for priority scheduling.

4. Can international patients receive treatment from Prof. Dr. Med. Michael Untch?

Yes. Cancer Rounds provides full assistance for international patients seeking treatment from Prof. Dr. Med. Michael Untch, including medical visa invitation letters, airport transfers, and local accommodation coordination.

5. What support is available for international patients?

International patients benefit from a dedicated concierge service provided by Cancer Rounds, including language interpretation, financial counselling, and pre-travel virtual consultations to review medical records before arrival.

6. Does Prof. Dr. Med. Michael Untch offer second opinions for Gynaecologist and Obstetrician, Medical Oncologist cases?

Yes. Second opinion consultations can be arranged via Cancer Rounds for patients who wish to review their diagnosis or treatment plan with an expert breast cancer and gynaecologic oncology specialist in Berlin, Germany.

Our Impact

CancerRounds is making quality care accessible to patients around the world

Send your reports
5000+ Specialists
Send your reports
500+ Partner Hospitals
Send your reports
10000+ Patients Served
Send your reports
98% Patient Satisfaction

Why Choose CancerRounds for Your Treatment?

World-Class Care

World-Class Care Highly

Skilled oncologists provide top-tier medical services

Affordable Treatment

Affordable Treatment

Costs are significantly lower than in Western countries.

Comprehensive Packages

Comprehensive Packages

We offer all-inclusive plans covering surgery, stay, and aftercare.

Easy Accessibility

Easy Accessibility

Well-connected airports and international flight routes. Proven Success: High patient satisfaction and positive treatment outcomes

Proven Success

Proven Success

High patient satisfaction and positive treatment outcomes


    Get FREE Evaluation

    Treatment plan and quote within 2 days

    FREE, No-Obligation Expert Evaluation

    👥 Trusted by Over 10,000 Patients Worldwide

    🤝 Expert Handholding at Every Step

    Your information is safe and confidential.